Skip to main content

Building

A better future

through education, skill development and research

LEARN MORE

Alcoholic Beverages Are Frequently Considered Migraine Triggers

In a European Journal of Neurology study of 2,197 patients who experience migraines, alcoholic beverages were reported as a trigger by 35.6 percent of participants.

Wednesday, December 19, 2018 12:01 am EST
"Alcohol-triggered migraine occurs rapid after intake of alcoholic beverages, suggesting a different mechanism than a normal hangover"

In a European Journal of Neurology study of 2,197 patients who experience migraines, alcoholic beverages were reported as a trigger by 35.6 percent of participants.

Additionally, more than 25 percent of migraine patients who had stopped consuming or never consumed alcoholic beverages did so because of presumed trigger effects. Wine, especially red wine (77.8 percent of participants), was recognized as the most common trigger among the alcoholic beverages; however, red wine consistently led to an attack in only 8.8 percent of participants. Time of onset was rapid (less than three hours) in one third of patients, and almost 90 percent of patients had an onset in under 10 hours independent of the type of alcoholic beverage consumed.

The authors noted that it can be debated if alcohol is a factual or a presumed trigger. Additional studies are needed to unravel this relationship.

“Alcohol-triggered migraine occurs rapid after intake of alcoholic beverages, suggesting a different mechanism than a normal hangover,” said senior author Dr. Gisela Terwindt, of the Leiden University Medical Center, in the Netherlands.

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/full/10.1111/ene.13861  

 About Journal 

The European Journal of Neurology is the official journal of the European Academy of Neurology and covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases of large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases).

About Wiley

Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company's website can be accessed at www.wiley.com.

Multimedia Files:

Preview image

Contact:

Josh Glickman +1 201-748-6572 (US)
Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com

Business Wire NewsHQsm